Seasonal malaria chemoprevention effectiveness in Northern Mozambique: Results from a cluster-randomised controlled trial
Published:
Resources: Presentation
Authors: Baltazar Candrinho
After adjusting for relevant variables on an intention-to-treat basis, seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine effectively prevented clinical malaria in eligible children during the peak transmission season in northern Mozambique.
To assess the effectiveness of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) for the prevention of clinical malaria in children aged 3–59 months during the high transmission season, a cluster-randomised controlled trial (cRCT) was carried out. The trial took place in two districts of Nampula province, Mozambique, between January and April 2022.
This presentation was given at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene
Tagged under:
Conference
American Society of Tropical Medicine and Hygiene Annual Meeting